Veradermics Oral Hair Loss Drug Succeeds in Study
Veradermics announced its oral minoxidil pill significantly increased hair growth in a late-stage study involving men with pattern hair loss. The treatment met all primary and secondary goals without serious side effects. Shares rose in premarket trading following the news.
Xurve View
Insights:
Xurve View
Veradermics reported that its oral pill increased hair growth in men with pattern hair loss during a late-stage study on Monday morning. Shares of the company rose 7.5% to $117 in premarket trading following the announcement. The treatment offers a novel oral alternative to existing topical applications in the hair-restoration market.
